Egyéb

Auto Draft

Your Title Goes Here 50% 50% Second line 23% 23%

Management

Chief executive officer László Puskás, PhD, DSc Dr. Puskás received a Master Degree in Biology (1994) and a PhD in chemistry (1997) at the Medical

Anticancer
Egyéb

Drug discovery

CANCER – Avinomid (Ac-2010) Researchers at Avidin have synthesized analogues of novel Immune Modulatory Drugs (IMIDs) which may have benefits over the current treatments for

In vivo toxicogenomics

Non-GLP toxicology, inflammationand cancer models Avidin is providing services for acute and sub-chronic toxicology of drug candidates in rats and mice and performs POC studies

Egyéb

In vivo imaging

IVIS® imaging technology (Xenogen/Caliper, USA) provides the most sensitive systems available – for both fluorescence and bioluminescence imaging. IVIS molecular imaging systems are designed to

Egyéb

Xenograft models

Avidin has established multiple in vivo assay systems to evaluate novel anti-cancer compounds. Our services include subcutaneous xenograft, orthotopic and syngeneic models and Maximum Tolerated

plate
Egyéb

In vitro toxicology

A) In vitro toxicology on cell cultures Avidin has more than 50 cell lines as well as primer neuronal cell cultures to test cytotoxicity of

László Puskás, PhD, DSc., CEO

Dr. Puskás received a Master Degree in Biology (1994) and a PhD in chemistry (1997) at the Medical Faculty of the University of Szeged, Hungary.